3 days popular7 days popular1 month popular3 months popular

Canada should ban asbestos use in Canada and globally

To prevent future cases of asbestos-related disease, Canada should institute a time-specific ban on asbestos use in Canada and support a global ban, states a commentary in CMAJ (Canadian Medical Association Journal). Asbestos causes mesothelioma as well as lung, larynx and ovarian cancer. “The tragic legacy of asbestos exposure, even among individuals who never knew [...]

Younger immigrants at higher risk of developing inflammatory bowel disease

The younger a person is when they immigrate to Canada, the higher their risk of developing inflammatory bowel disease (IBD), and its major subtypes Crohn’s disease and ulcerative colitis, according to a study by researchers at the University of Ottawa, the Institute for Clinical Evaluative Sciences (ICES) and the Children’s Hospital of Eastern Ontario (CHEO). [...]

Doctors have important role in drafting legislation for assisted dying in Canada over the next 12 months

Physicians in Canada must be involved in shaping the legal framework to help protect patients and allow competent adults to make decisions about their lives in the lead up to legal physician-assisted dying, argues a commentary in CMAJ (Canadian Medical Association Journal). On Feb. 6, 2015, the Supreme Court of Canada unanimously ruled that prohibitions [...]

Nocturnal leg cramps more common in summer

Painful nocturnal leg cramps are about twice as common during summer than in winter, found a new study in CMAJ (Canadian Medical Association Journal). Because quinine is commonly prescribed to treat leg cramps, researchers looked at the number of new quinine prescriptions for adults over 50 years of age in British Columbia, Canada, from Dec. [...]

First and only treatment for multicentric Castleman’s disease, SYLVANT, now approved in Canada

Janssen Inc. has announced that Health Canada has approved SYLVANTTM (siltuximab) for the treatment of patients with multicentric Castleman’s disease (MCD) who are human immunodeficiency virus (HIV)-negative and human herpes virus-8 (HHV-8)-negative. SYLVANTTM is the first clinically proven treatment approved in Canada for MCD. [i] Multicentric Castleman’s disease is a rare condition and therefore it [...]